Prognostic factors of pediatric hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Pediatric patients who received hematopoietic stem cell transplantation (HSCT) tend to have high morbidity and mortality. While, the prognostic factors of adult patients received bone marrow transplantation were already known, there is little known in pediatric pateints. This study aimed to identify the prognostic factor for pediatric intensive care unit (PICU) mortality of critically ill pediatric patients with HSCT. Methods: Retrospectively reviewed that the medical records of patients who received HSCT and admitted to PICU between January 2010 and December 2019. Mortality was defined a patient who expired within 28 days. Results: A total of 131 patients were included. There were 63 boys (48.1%) and median age was 11 years (interquartile range, 4–15 years). The most common HSCT type was haploidentical (38.9%) and respiratory failure (44.3%) was the most common reason for PICU admission. Twenty-eight– day mortality was 22.1% (29/131). In comparison between survivors and non-survivors, the number of HSCTs received, sepsis, oncological pediatric risk of mortality-III (OPRISM-III), pediatric risk of mortality-III (PRISM-III), pediatric Sequential Organ Failure Assessment (pSOFA), serum lactate, B-type natriuretic peptide (BNP) and use of mechanical ventilator (MV) and vasoactive inotropics were significant predictors (P<0.05 for all variables). In multivariate logistic regression, the number of HSCTs received, use of MV, OPRISM-III, PRISM-III and pSOFA were independent risk factors of PICU mortality. Moreover, three scoring systems were significant prognostic factors of 28-day mortality. Conclusions: The number of HSCTs received and use of MV were more accurate predictors in pediatric patients received HSCT.
Abstract
Background: Pediatric patients who received hematopoietic stem cell transplantation (HSCT) tend to have high morbidity and mortality. While, the prognostic factors of adult patients received bone marrow transplantation were already known, there is little known in pediatric pateints. This study aimed to identify the prognostic factor for pediatric intensive care unit (PICU) mortality of critically ill pediatric patients with HSCT. Methods: Retrospectively reviewed that the medical records of patients who received HSCT and admitted to PICU between January 2010 and December 2019. Mortality was defined a patient who expired within 28 days. Results: A total of 131 patients were included. There were 63 boys (48.1%) and median age was 11 years (interquartile range, 4–15 years). The most common HSCT type was haploidentical (38.9%) and respiratory failure (44.3%) was the most common reason for PICU admission. Twenty-eight– day mortality was 22.1% (29/131). In comparison between survivors and non-survivors, the number of HSCTs received, sepsis, oncological pediatric risk of mortality-III (OPRISM-III), pediatric risk of mortality-III (PRISM-III), pediatric Sequential Organ Failure Assessment (pSOFA), serum lactate, B-type natriuretic peptide (BNP) and use of mechanical ventilator (MV) and vasoactive inotropics were significant predictors (P<0.05 for all variables). In multivariate logistic regression, the number of HSCTs received, use of MV, OPRISM-III, PRISM-III and pSOFA were independent risk factors of PICU mortality. Moreover, three scoring systems were significant prognostic factors of 28-day mortality. Conclusions: The number of HSCTs received and use of MV were more accurate predictors in pediatric patients received HSCT.
참고문헌 (38)
- Savaşan S, "Current issues in pediatric stem cell transplantation", Clin Lab Med, 25, pp.519~540 (2005)
- Gratwohl A, "Hematopoietic stem cell transplantation : a global perspective", JAMA, 303, pp.1617~1624 (2010)
- Appelbaum FR, "Hematopoietic-cell transplantation at 50", N Engl J Med, 357, pp.1472~1475 (2007)
- Copelan EA, "Hematopoietic stem-cell transplantation", N Engl J Med, 354, pp.1813~1826 (2006)
- Oudin C, "Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies", Haematologica, 99, pp.1762~1768 (2014)
- Bacigalupo A, "Defining the intensity of conditioning regimens : working definitions", Biol Blood Marrow Transplant, 15, pp.1628~1633 (2009)
- Passweg JR, "Hematopoietic SCT in Europe : data and trends in 2012 with special consideration of pediatric transplantation", Bone Marrow Transplant, 49, pp.744~750 (2014)
- Gooley TA, "Reduced mortality after allogeneic hematopoietic-cell transplantation", N Engl J Med, 363, pp.2091~2101 (2010)
- Azoulay E, "The intensive care support of patients with malignancy : do everything that can be done", Intensive Care Med, 32, pp.3~5 (2006)
- Pène F, "Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients : a reappraisal of indications for organ failure supports", J Clin Oncol, 24, pp.643~649 (2006)
- Platon L, "A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors : results of a 5-year cohort study(2009-2013)", Bone Marrow Transplant, 51, pp.256~261 (2016)
- Benz R, "Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT", Bone Marrow Transplant, 49, pp.62~65 (2014)
- Saillard C, "Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit : reappraisal of actual prognosis", Bone Marrow Transplant, 51, pp.1050~1061 (2016)
- Saillard C, "Critically ill allogenic HSCT patients in the intensive care unit : a systematic review and meta-analysis of prognostic factors of mortality", Bone Marrow Transplant, 53, pp.1233~1241 (2018)
- Pollack MM, "PRISM III : an updated pediatric risk of mortality score", Crit Care Med, 24, pp.743~752 (1996)
- Matics TJ, "Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children", JAMA Pediatr, 171, pp.e172352~ (2017)
- Schneider DT, "Introduction of the oncological pediatric risk of mortality score(O-PRISM)for ICU support following stem cell transplantation in children", Bone Marrow Transplant, 25, pp.1079~1086 (2000)
- Soubani AO, "Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU", Chest, 126, pp.1604~1611 (2004)
- Jacobe SJ, "Outcome of children requiring admission to an intensive care unit after bone marrow transplantation", Crit Care Med, 31, pp.1299~1305 (2003)
- Keenan HT, "Outcome of children who require mechanical ventilatory support after bone marrow transplantation", Crit Care Med, 28, pp.830~835 (2000)
- Mokart D, "Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen : outcomes of patients admitted to intensive care unit", J Crit Care, 30, pp.1107~1113 (2015)
- 최혜선, "조혈모세포이식 후 중환자실 치료를 받은 소아 환자의 예후 예견 인자 분석", Acute and Critical Care, 26(4), pp.226~231 (2011), 대한중환자의학회
- González-Vicent M, "Risk score for pediatric intensive care unit admission in children undergoing hematopoietic stem cell transplantation and analysis of predictive factors for survival", J Pediatr Hematol Oncol, 27, pp.526~531 (2005)
- Cheuk DK, "Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant", Hematol Oncol, 22, pp.1~9 (2004)
- Tomaske M, "Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation", Br J Haematol, 121, pp.886~891 (2003)
- Zinter MS, "Comprehensive prognostication in critically ill pediatric hematopoietic cell transplant patients : results from merging the center for international blood and marrow transplant research(CIBMTR)and virtual pediatric systems(VPS)registries", Biol Blood Marrow Transplant, 26, pp.333~342 (2020)
- Lamas A, "Prognosis of child recipients of hematopoietic stem cell transplantation requiring intensive care", Intensive Care Med, 29, pp.91~96 (2003)
- Kwon R, "The outcomes of pediatric hematopoietic stem cell transplantation recipients requiring intensive care unit admission : a single center experience", Transl Perioper Pain Med, 6, pp.75~80 (2019)
- Kumar G, "Milwaukee initiative in critical care outcomes research group of investigators : severe sepsis in hematopoietic stem cell transplant recipients", Transl Perioper Pain Med, 6, pp.75~80 (2019)
- Fernández-García M, "Intensive care unit admissions among children after hematopoietic stem cell transplantation: incidence, outcome, and prognostic factors", J Pediatr Hematol Oncol, 37, pp.529~535 (2015)
- Schneider DT, "Serial evaluation of the oncological pediatric risk of mortality(O-PRISM)score following allogeneic bone marrow transplantation in children", Bone Marrow Transplant, 29, pp.383~389 (2002)
- Torrecilla C, "Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy", Intensive Care Med, 14, pp.393~398 (1988)
- Staudinger T, "Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit", Crit Care Med, 28, pp.1322~1328 (2000)
- Pène F, "Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit", Crit Care Med, 36, pp.690~696 (2008)
- Zuber B, "Impact of case volume on survival of septic shock in patients with malignancies", Crit Care Med, 40, pp.55~62 (2012)
- McGowan JV, "Anthracycline chemotherapy and cardiotoxicity", Cardiovasc Drugs Ther, 31, pp.63~75 (2017)
- Dhesi S, "Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management", J Investig Med High Impact Case Rep, 1 (2013)
- Snowden JA, "Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide", Bone Marrow Transplant, 26, pp.309~313 (2000)